1 Everolimus for renal angiomyolipoma associated with tuberous sclerosis complex (TSC) from EXIST-2: Continued efficacy and diminishing adverse events after ∼3.5 years of treatment
2015
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI